Literature DB >> 15160865

Morbihan's disease: treatment with CO2 laser blepharoplasty.

Falk Georges Bechara1, Thomas Jansen, Rüdiger Losch, Peter Altmeyer, Klaus Hoffmann.   

Abstract

Morbihan's disease is a rare condition characterized by chronic persistent erythema and edema of the upper half of the face. Therapeutic regimens such as X-ray irradiation, lymphatic massage, interferon gamma injections, antihistamines, and high-dose antibiotics are often unsatisfactory. Promising results in some patients have been achieved by a systemic combination therapy of isotretinoin with ketotifen or clofazimine. Excision of redundant edematous tissue may be an alternative. We present a 67-year-old Caucasian patient with a two-year history of right lower and upper eyelid swelling and erythema. Systemic therapies with corticocosteroids and antibiotics were not successful, but CO2 laser blepharoplasty led to good cosmetic results with marked improvement of visual impairment and no recurrence during the six-month follow-up period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15160865     DOI: 10.1111/j.1346-8138.2004.tb00518.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

1.  Morbihan syndrome.

Authors:  Stefano Veraldi; Maria Chiara Persico; Claudia Francia
Journal:  Indian Dermatol Online J       Date:  2013-04

2.  Successful treatment of solid persistent facial edema with isotretinoin and compression therapy.

Authors:  Haley D Heibel; Mark D Heibel; Clay J Cockerell
Journal:  JAAD Case Rep       Date:  2020-06-15

Review 3.  Efficacy of long-term intralesional triamcinolone in Morbihan's disease and its possible association with mast cell infiltration.

Authors:  Aikaterini Tsiogka; Josef Koller
Journal:  Dermatol Ther       Date:  2018-04-23       Impact factor: 2.851

4.  Morbihan disease: A diagnostic dilemma: two cases with successful resolution.

Authors:  Deepak Donthi; Joseph Nenow; Arthur Samia; Charles Phillips; John Papalas; Karyn Prenshaw
Journal:  SAGE Open Med Case Rep       Date:  2021-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.